81 related articles for article (PubMed ID: 22517000)
1. [Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis].
Lei L; Zhong XN; Zhao C; Mi CD; Li JQ; Zeng JJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):259-64. PubMed ID: 22517000
[TBL] [Abstract][Full Text] [Related]
2. Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
Seki N; Tsujimoto H; Tanemura S; Ishigaki S; Takei H; Sugahara K; Yoshimoto K; Akiyama M; Kaneko Y; Chiba K; Takeuchi T
Cytokine; 2024 Apr; 176():156534. PubMed ID: 38354516
[TBL] [Abstract][Full Text] [Related]
3. Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement.
Nicola S; Rolla G; Bucca C; Geronazzo G; Ridolfi I; Ferraris A; Fusaro E; Peroni CL; Dughera L; Brussino L
Cells; 2020 Sep; 9(9):. PubMed ID: 32947843
[TBL] [Abstract][Full Text] [Related]
4.
Wang K; Dong H; Qi Y; Pei Z; Yi S; Yang X; Zhao Y; Meng F; Yu S; Zhou T; Hu G
Can J Vet Res; 2017 Apr; 81(2):122-128. PubMed ID: 28408780
[TBL] [Abstract][Full Text] [Related]
5. Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.
Yoshizaki A; Yanaba K; Iwata Y; Komura K; Ogawa A; Akiyama Y; Muroi E; Hara T; Ogawa F; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Tedder TF; Sato S
J Immunol; 2010 Aug; 185(4):2502-15. PubMed ID: 20624949
[TBL] [Abstract][Full Text] [Related]
6. Persistence of Th17/Tc17 cell expression upon smoking cessation in mice with cigarette smoke-induced emphysema.
Duan MC; Tang HJ; Zhong XN; Huang Y
Clin Dev Immunol; 2013; 2013():350727. PubMed ID: 24489575
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of peripheral Th17 cells and Th17-related cytokines in patients with periampullary adenocarcinoma.
Khan IA; Singh N; Gunjan D; Dash NR; Nayak B; Gupta S; Saraya A
Hum Immunol; 2024 Jan; 85(1):110748. PubMed ID: 38177009
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous intestinal tumorigenesis.
Shapiro M; Nandi B; Pai C; Samur MK; Pelluru D; Fulciniti M; Prabhala RH; Munshi NC; Gold JS
Cancer Immunol Immunother; 2016 Jan; 65(1):13-24. PubMed ID: 26559812
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma.
Khan IA; Singh N; Gunjan D; Gopi S; Dash NR; Gupta S; Saraya A
Immunogenetics; 2023 Oct; 75(5):433-443. PubMed ID: 37540314
[TBL] [Abstract][Full Text] [Related]
10. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.
de Almeida AR; Dantas AT; de Oliveira Gonçalves ME; Chêne C; Jeljeli M; Chouzenoux S; Thomas M; Cunha EGC; de Azevedo Valadares LD; de Melo Gomes JV; de Paula SKS; da Rocha Pitta MG; da Rocha Pitta I; de Melo Rêgo MJB; Pereira MC; Duarte ALBP; Abdalla DSP; Nicco C; Batteux F; da Rocha Pitta MG
Inflammopharmacology; 2024 Feb; 32(1):433-446. PubMed ID: 37477795
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the dynamic changes of γδT cells, Th17 cells, CD4
Liu W; Zhang JH; Gao L; Xiao JH
Exp Cell Res; 2024 Jun; 439(1):114098. PubMed ID: 38796136
[TBL] [Abstract][Full Text] [Related]
12. TLR8 aggravates skin inflammation and fibrosis by activating skin fibroblasts in systemic sclerosis.
Kong X; Jiang S; He Q; Shi X; Pu W; Huang Y; Ma Y; Liu Q; Sun D; Huang D; Wu F; Li P; Tu W; Zhao Y; Wang L; Chen Y; Wu W; Tang Y; Zhao X; Zhu Q; Gao J; Xu W; Shui X; Qian F; Wang J
Rheumatology (Oxford); 2024 May; 63(6):1710-1719. PubMed ID: 37665747
[TBL] [Abstract][Full Text] [Related]
13. Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
Morozan A; Joy S; Fujii U; Fraser R; Watters K; Martin JG; Colmegna I
Sci Rep; 2023 Nov; 13(1):20577. PubMed ID: 37996447
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling.
Park JS; Kim C; Choi J; Jeong HY; Moon YM; Kang H; Lee EK; Cho ML; Park SH
J Transl Med; 2024 Apr; 22(1):323. PubMed ID: 38561750
[TBL] [Abstract][Full Text] [Related]
15. RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cells.
Mortier C; Gracey E; Coudenys J; Manuello T; Decruy T; Maelegheer M; Stappers F; Gilis E; Gaublomme D; Van Hoorebeke L; Van Welden S; Ambler C; Hegen M; Symanowicz P; Steyn S; Berstein G; Elewaut D; Venken K
Rheumatology (Oxford); 2023 Sep; 62(9):3169-3178. PubMed ID: 36661300
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of
Erice PA; Huang X; Seasock MJ; Robertson MJ; Tung HY; Perez-Negron MA; Lotlikar SL; Corry DB; Kheradmand F; Rodriguez A
Elife; 2024 May; 13():. PubMed ID: 38722677
[TBL] [Abstract][Full Text] [Related]
17. RORγt protein modifications and IL-17-mediated inflammation.
Kumar R; Theiss AL; Venuprasad K
Trends Immunol; 2021 Nov; 42(11):1037-1050. PubMed ID: 34635393
[TBL] [Abstract][Full Text] [Related]
18. Skin and lung fibrosis induced by bleomycin in mice: a systematic review.
Gülle S; Çelik A; Birlik M; Yılmaz O
Reumatismo; 2024 Mar; 76(1):. PubMed ID: 38523580
[TBL] [Abstract][Full Text] [Related]
19. Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study.
Kosałka-Węgiel J; Lichołai S; Pacholczak-Madej R; Dziedzina S; Milewski M; Kuszmiersz P; Korona A; Gąsior J; Matyja-Bednarczyk A; Kwiatkowska H; Zaręba L; Siwiec-Koźlik A; Koźlik-Siwiec P; Wach A; Pociej-Marciak W; Sanak M; Musiał J; Bazan-Socha S; Korkosz M
Rheumatol Int; 2024 Jan; 44(1):119-128. PubMed ID: 38051374
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis.
Jeong HY; Park JS; Woo JS; Lee KH; Choi JW; Kang HY; Na HS; Lee YS; Um IG; Park SH; Cho ML
J Inflamm (Lond); 2023 Dec; 20(1):46. PubMed ID: 38129904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
